Compare LMAT & LU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LMAT | LU |
|---|---|---|
| Founded | 1983 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.2B |
| IPO Year | 2006 | 2020 |
| Metric | LMAT | LU |
|---|---|---|
| Price | $83.45 | $2.61 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $101.83 | N/A |
| AVG Volume (30 Days) | 188.5K | ★ 1.5M |
| Earning Date | 11-06-2025 | 03-23-2026 |
| Dividend Yield | ★ 0.95% | N/A |
| EPS Growth | ★ 27.40 | N/A |
| EPS | ★ 2.32 | N/A |
| Revenue | $240,866,000.00 | ★ $4,671,260,668.00 |
| Revenue This Year | $15.17 | N/A |
| Revenue Next Year | $9.07 | $1.94 |
| P/E Ratio | $36.21 | ★ N/A |
| Revenue Growth | ★ 13.07 | N/A |
| 52 Week Low | $71.42 | $2.25 |
| 52 Week High | $105.55 | $4.57 |
| Indicator | LMAT | LU |
|---|---|---|
| Relative Strength Index (RSI) | 43.71 | 43.80 |
| Support Level | $82.52 | $2.62 |
| Resistance Level | $85.21 | $2.76 |
| Average True Range (ATR) | 2.32 | 0.09 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 33.21 | 48.39 |
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
Lufax Holding Ltd is a technology-empowered personal financial services platform in China. The company address the large unmet demand for personal lending among small business owners as well as salaried workers in China and provides tailor-made wealth management solutions to China's middle class and affluent population. Its platform has two hubs namely Retail Credit Facilitation Hub and Wealth Management Hub.